Skip to main content
. Author manuscript; available in PMC: 2015 Feb 5.
Published in final edited form as: Antivir Ther. 2014 Oct 13;19(0 3):15–29. doi: 10.3851/IMP2897

Figure 1.

Figure 1

Figure 1

Significant antiretroviral therapy APIs for low- and middle-income countries

API, active pharmaceutical ingredient; NNRTI, non-nucleoside/nucleotide reverse transcriptase inhibitor; NRTI, nucleoside/nucleotide reverse transcriptase inhibitor; PI, protease inhibitor; PPPY, per-patient-per-year.